EPS for Perrigo Company plc (PRGO) Expected At $1.23

July 14, 2018 - By Benjamin Allen

Perrigo Company plc (NYSE:PRGO) LogoInvestors sentiment decreased to 0.88 in 2018 Q1. Its down 0.19, from 1.07 in 2017Q4. It turned negative, as 39 investors sold Perrigo Company plc shares while 133 reduced holdings. 42 funds opened positions while 110 raised stakes. 102.96 million shares or 0.26% more from 102.69 million shares in 2017Q4 were reported.
Fmr Limited Liability Co owns 397,429 shares or 0% of their US portfolio. Rbf Lc reported 4,800 shares. Gradient Invs Ltd Liability holds 0% of its portfolio in Perrigo Company plc (NYSE:PRGO) for 3 shares. Convergence Prtnrs Ltd Liability invested in 0.01% or 603 shares. Chevy Chase Tru Hldgs Inc reported 0.04% stake. Clinton holds 0.02% or 2,664 shares. Cleararc Cap owns 2,986 shares. Mutual Of America Capital Mgmt Ltd Liability owns 16,774 shares. Nomura Holdg has 18,653 shares for 0% of their portfolio. Brinker Capital holds 8,496 shares or 0.03% of its portfolio. Tokio Marine Asset Mngmt Com Ltd holds 0.2% of its portfolio in Perrigo Company plc (NYSE:PRGO) for 13,923 shares. The Texas-based Employees Retirement Systems Of Texas has invested 0.01% in Perrigo Company plc (NYSE:PRGO). Royal Financial Bank Of Canada invested in 38,431 shares or 0% of the stock. Heartland Advisors has invested 0.02% in Perrigo Company plc (NYSE:PRGO). Comml Bank Of Nova Scotia stated it has 3,629 shares or 0% of all its holdings.

Analysts expect Perrigo Company plc (NYSE:PRGO) to report $1.23 EPS on August, 9.They anticipate $0.01 EPS change or 0.82 % from last quarter’s $1.22 EPS. PRGO’s profit would be $170.30M giving it 15.43 P/E if the $1.23 EPS is correct. After having $1.26 EPS previously, Perrigo Company plc’s analysts see -2.38 % EPS growth. The stock decreased 0.16% or $0.12 during the last trading session, reaching $75.9. About 704,278 shares traded. Perrigo Company plc (NYSE:PRGO) has risen 4.72% since July 14, 2017 and is uptrending. It has underperformed by 7.85% the S&P500.

Perrigo Company plc (NYSE:PRGO) Ratings Coverage

Among 10 analysts covering Perrigo Co (NYSE:PRGO), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Perrigo Co had 12 analyst reports since February 1, 2018 according to SRatingsIntel. The stock of Perrigo Company plc (NYSE:PRGO) has “Buy” rating given on Tuesday, February 27 by Canaccord Genuity. The stock has “Buy” rating by Cantor Fitzgerald on Tuesday, May 8. As per Monday, May 14, the company rating was maintained by Cantor Fitzgerald. Goldman Sachs downgraded Perrigo Company plc (NYSE:PRGO) on Thursday, July 12 to “Sell” rating. The company was maintained on Monday, March 5 by JP Morgan. RBC Capital Markets maintained the stock with “Hold” rating in Sunday, March 4 report. The stock of Perrigo Company plc (NYSE:PRGO) has “Buy” rating given on Friday, March 2 by Cantor Fitzgerald. The company was maintained on Monday, March 5 by Oppenheimer. The stock has “Market Perform” rating by Wells Fargo on Monday, May 14. On Wednesday, June 6 the stock rating was downgraded by Barclays Capital to “Equal-Weight”.

Perrigo Company plc, together with its subsidiaries, develops, makes, markets, and distributes over-the-counter consumer goods and pharmaceutical products worldwide. The company has market cap of $10.51 billion. It offers OTC products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. It has a 90.36 P/E ratio. The firm also provides generic and specialty pharmaceutical prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations.

More important recent Perrigo Company plc (NYSE:PRGO) news were published by: Gurufocus.com which released: “Analysts Revamp Ratings on Healthcare Stocks” on July 13, 2018, also Benzinga.com published article titled: “Benzinga’s Top Upgrades, Downgrades For July 12, 2018”, Benzinga.com published: “Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings” on July 12, 2018. More interesting news about Perrigo Company plc (NYSE:PRGO) was released by: Benzinga.com and their article: “8 Biggest Price Target Changes For Thursday” with publication date: July 12, 2018.

Perrigo Company plc (NYSE:PRGO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.